BROWN UNIVERSITY
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1764-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.brown.edu
Contingency Management for Smoking in Substance Abusers
- Conditions
- Interventions
- First Posted Date
- 2008-12-12
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Brown University
- Target Recruit Count
- 340
- Registration Number
- NCT00807742
- Locations
- 🇺🇸
Brown University, Center for Alcohol and Addiction Studies, Providence, Rhode Island, United States
Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans
- Conditions
- Interventions
- First Posted Date
- 2008-11-18
- Last Posted Date
- 2011-06-22
- Lead Sponsor
- Brown University
- Target Recruit Count
- 75
- Registration Number
- NCT00792519
- Locations
- 🇰🇪
AMPATH Centre, Eldoret, Rift Valley, Kenya
A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)
- Conditions
- First Posted Date
- 2008-11-10
- Last Posted Date
- 2014-07-30
- Lead Sponsor
- Brown University
- Target Recruit Count
- 11
- Registration Number
- NCT00787852
- Locations
- 🇺🇸
Lifespan Hospitals, Providence, Rhode Island, United States
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
- Conditions
- Interventions
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2018-08-27
- Lead Sponsor
- Brown University
- Target Recruit Count
- 158
- Registration Number
- NCT00756275
- Locations
- 🇺🇸
Brown University, Center for Alcohol and Addiction Studies, Providence, Rhode Island, United States
Decitabine, Cytarabine, GCSF for Refractory AML/MDS
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Brown University
- Target Recruit Count
- 9
- Registration Number
- NCT00740181
- Locations
- 🇺🇸
Lifespan Hospitals, Providence, Rhode Island, United States
Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
- First Posted Date
- 2008-07-17
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Brown University
- Target Recruit Count
- 41
- Registration Number
- NCT00717756
- Locations
- 🇺🇸
Memorial Hospital of Rhode island, Pawtucket, Rhode Island, United States
🇺🇸Lifespan Hospitals, Providence, Rhode Island, United States
🇺🇸Montefiore Medical Center, Bronx, New York, United States
Group Therapy for Women Prisoners With Comorbid Substance Use and Depression
- First Posted Date
- 2008-02-05
- Last Posted Date
- 2013-04-18
- Lead Sponsor
- Brown University
- Target Recruit Count
- 38
- Registration Number
- NCT00606996
- Locations
- 🇺🇸
Adult Correctional Institution, Cranston, Rhode Island, United States
Neoadjuvant Paclitaxel Poliglumex, Cisplatin and Radiation for Esophageal Cancer: A Phase II Trial (CTI#X64001)
- First Posted Date
- 2007-08-30
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Brown University
- Target Recruit Count
- 40
- Registration Number
- NCT00522795
- Locations
- 🇺🇸
Lifespan Hospitals, Providence, Rhode Island, United States
Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse
- First Posted Date
- 2007-04-19
- Last Posted Date
- 2019-04-09
- Lead Sponsor
- Brown University
- Target Recruit Count
- 18
- Registration Number
- NCT00462865
- Locations
- 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
🇺🇸Lifespan Hospitals, Providence, Rhode Island, United States
🇺🇸Women & Infants' Hospital, Providence, Rhode Island, United States
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Brown University
- Target Recruit Count
- 25
- Registration Number
- NCT00447122
- Locations
- 🇺🇸
Lifespan Hospitals, Providence, Rhode Island, United States